Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · IEX Real-Time Price · USD

1.330

+0.170 (14.66%)

At close: Apr 26, 2024, 3:59 PM

1.320

-0.010 (-0.75%)

After-hours: Apr 26, 2024, 4:00 PM EDT

Alaunos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Net Income	-35.14	-37.73	-78.75	-79.98	-117.8	137.25	-73.26	-172.42	-120.09	-31.78	Upgrade
Depreciation & Amortization	2.6	3.25	2.25	1.13	0.63	0.58	0.37	0.29	0.36	0.46	Upgrade
Share-Based Compensation	2.8	3.53	10.77	6.83	7.34	7.53	8.45	8.45	8	4.74	Upgrade
Other Operating Activities	-0.4	1.73	4.26	15.01	68.97	-211.81	-9.17	98.23	111.72	-10.07	Upgrade
Operating Cash Flow	-30.14	-29.23	-61.47	-57.01	-40.85	-49.46	-54.67	-58.33	-0.01	-36.65	Upgrade
Capital Expenditures	1.35	-0.19	-3.32	-9.78	-0.28	-0.46	-0.74	-0.55	-0.41	-0.19	Upgrade
Investing Cash Flow	1.35	-0.19	-3.32	-9.78	-0.28	-0.46	-0.74	-0.55	-0.41	-0.19	Upgrade
Share Issuance / Repurchase	0.09	14.7	1.04	102.12	59.15	-1.38	45.3	-0.79	98.34	11.44	Upgrade
Debt Issued / Paid	-18.23	-8.33	24.74	0	0	47.1	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-	-5.41	-	-	-	-	Upgrade
Financing Cash Flow	-18.14	6.37	25.78	102.12	59.15	40.31	45.3	-0.79	98.34	11.44	Upgrade
Net Cash Flow	-46.93	-23.06	-39.02	35.33	18.01	-9.61	-10.11	-59.66	97.91	-25.4	Upgrade
Free Cash Flow	-28.8	-29.43	-64.79	-66.79	-41.14	-49.92	-55.41	-58.88	-0.42	-36.84	Upgrade
Free Cash Flow Margin	-575920.00%	-1007.02%	-16279.15%	-	-	-34189.04%	-867.21%	-858.13%	-9.74%	-2683.39%	Upgrade
Free Cash Flow Per Share	-1.80	-2.03	-4.53	-4.78	-3.67	-5.22	-6.07	-6.77	-0.05	-5.46	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).